Corrective Phases R...
Health Care: Drugs
BioDelivery Sciences International Inc. (BDSI: NASDAQ)
$3.17 -0.21 | -6.21%
06/04/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 10.75M | 18.21M | 23.87M | 905.72K |
| Receivables | 101.13K | 633.22K | 1.27M | 468.99K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 11.08M | 19.08M | 25.43M | 1.56M |
| Property, Plant & Equipment, Gross | 5.43M | 5.12M | 5.01M | 2.04M |
| Accumulated Depreciation & Depletion | 2.14M | 1.69M | 1.27M | 1.91M |
| Property, Plant & Equipment, Net | 3.29M | 3.42M | 3.74M | 126.73K |
| Intangibles | 6.15M | 7.04M | 7.13M | 5.83M |
| Other Non-Current Assets | 410.52K | 1.32M | 660.58K | 3.11M |
| Total Non-Current Assets | 12.56M | 14.50M | 14.25M | 11.78M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 23.65M | 33.58M | 39.68M | 13.34M |
| Accounts Payable | 5.09M | 4.66M | 6.57M | 2.94M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 279.30K | 4.99M | 5.29M | 5.35M |
| Total Current Liabilities | 17.88M | 22.14M | 23.62M | 45.29M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 1.65M | 1.66M | 1.60M | 1.63M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 1.65M | 1.66M | 1.60M | 1.63M |
| Total Liabilities | 19.52M | 23.79M | 25.22M | 46.92M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 4.12M | 9.79M | 14.46M | -33.58M |
| Common Par | 29.58K | 24.04K | 21.18K | 19.18K |
| Additional Paid In Capital | 99.71M | 82.06M | 73.70M | 58.71M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -95.57M | -72.25M | -59.21M | -92.26M |
| Treasury Stock | -47.18K | -47.18K | -47.18K | -47.18K |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 4.12M | 9.79M | 14.46M | -33.58M |
| Total Equity | 4.12M | 9.79M | 14.46M | -33.58M |
| Total Liabilities & Stock Equity | 23.65M | 33.58M | 39.68M | 13.34M |
| Total Common Shares Outstanding | 29.56M | 24.02M | 21.17M | 19.16M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 15.49K | 15.49K | 15.49K | 15.49K |
| Basic Weighted Shares Outstanding | 28.32M | 23.15M | 20.22M | 19.16M |
| Diluted Weighted Shares Outstanding | 28.32M | 23.15M | 21.50M | 19.16M |
| Number of Employees | 17 | 20 | 16 | 20 |
| Number of Part-Time Employees | 1 | 1 | 1 | 2 |
Portfolios with BDSI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- UserWatchlist
- UserWhole Portfolio
- Userespwes06 Portfolio 1
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks Under $5 Outperfo...
- Contributor10 Pharma Stocks With 100% ...
- UserSmall Cap Bargains to follo...
- UserPROS
- UserCloud66 - IRA
Latest BDSI Headlines from TheStreet
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- The Next Big Thing in Biotech: BIO CEO Conference
02.10.12 | 05:02 am - 10 Stocks Under $5 Outperforming in 2012 01.31.12 | 05:01 am
- Biotech Stock Mailbag: Adventrx Pharma 07.15.11 | 05:07 am
- BioDelivery Sciences International Inc. Stock Downgraded (BDSI) 04.01.11 | 06:04 pm
- IPO Watch: 2011 02.16.11 | 01:02 pm
- 10 Pharma Stocks With 100% Buy Ratings 02.03.11 | 11:02 am
- Rodman Rambles: Promising Biotechs 09.15.10 | 10:09 am
- Biotech Calendar: Key Dates for September 09.01.10 | 07:09 am
- Stock Offerings: MGIC Investment 04.20.10 | 11:04 am
Press Releases for BDSI
- BioDelivery Sciences To Present At The Jefferies 2012 Global Healthcare Conference - PR Newswire 05.31.12 | 07:05 am
- BioDelivery Sciences Receives $2.5 Million Milestone From Meda For BREAKYL In E.U. - PR Newswire 05.21.12 | 07:05 am
- BioDelivery Sciences Awarded Patent Resulting In $15 Million Milestone Payment - PR Newswire 04.17.12 | 07:04 am
- BioDelivery Sciences To Present At The Future Leaders In The Biotech Industry Conference - PR Newswire 04.16.12 | 08:04 am
- BioDelivery Sciences To Host Opioid Dependence Investor Event And Webcast On April 11, 2012 - PR Newswire 04.05.12 | 08:04 am
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its Annual Report - PR Newswire 03.19.12 | 04:03 pm
- Federal Court Grants Request By BioDelivery Sciences For Stay Of MonoSol Litigation - PR Newswire 03.14.12 | 07:03 am
- ONSOLIS Relaunch Postponed Pending Product Modification - PR Newswire 03.12.12 | 07:03 am
- US Patent Office Rejection Of All Claims In Final Asserted MonoSol Patent Further Supports BioDelivery Sciences' Position - PR Newswire 03.06.12 | 09:03 am
- BioDelivery Sciences To Present At Cowen And ROTH Conferences - PR Newswire 03.05.12 | 07:03 am
Partner Headlines for BDSI
- BioDelivery's Spike May Be A Short-Lived Downer - Seeking Alpha 04.04.12 | 08:04 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- BioDelivery Sciences Provides Business Review - Benzinga 03.19.12 | 04:03 pm
- Legal Developments Bode Well For BioDelivery Sciences - Seeking Alpha 03.15.12 | 08:03 am
- Biopharma Stocks To Watch This Week - Seeking Alpha 01.19.12 | 09:01 am
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- This Week's Healthcare Stock Watch - Seeking Alpha 09.20.11 | 09:09 am
- Options Brief: BioDelivery Sciences International (BDSI) - Benzinga 12.28.10 | 09:12 am
- BioDelivery Sciences: Signs of Life - Seeking Alpha 09.10.10 | 03:09 pm
- BioDelivery Sciences Hopes to Increase Access to Cancer-Pain Drug - Fox Business 09.02.10 | 05:09 pm
